---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-087267"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:41:59.025453+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# CERo Therapeutics reports $3.3M preliminary cash; appoints Shami Patel to board

## Summary
- Preliminary unaudited cash and cash equivalents as of Sept 30, 2024 were approximately $3.3 million.
- Board appointed Shami Patel as Class III director effective Oct 11, 2024, filling vacancy from Dr. Corey's resignation.
- Cash estimate is preliminary and subject to change upon completion of quarter-end close; no audit performed.
- Patel is a Managing Director at Launchpad Capital with extensive SPAC and financial services experience.

## SEC filing metadata
- accession: 0001213900-24-087267
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/0001213900-24-087267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/ea0217430-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-087267
- JSON: https://secwatch.observer/filing/0001213900-24-087267.json
- Plain text: https://secwatch.observer/filing/0001213900-24-087267.txt

## Key facts
- Executive change
  Shami Patel was appointed as Class III Director at CERO THERAPEUTICS HOLDINGS, INC..
  - Action: appointed
  - Role: Class III Director
  source text: On October 9, 2024, the Board of Directors (the “ Board ”) of the Company appointed Shami Patel to the Board as a Class III director, effective October 11, 2024, to fill the vacancy created by Dr. Corey’s resignation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/0001213900-24-087267-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.